Big Data Approaches to Phenotyping Acute Ischemic Stroke Using Automated Lesion Segmentation of Multi-Center Magnetic Resonance Imaging Data

  • Ona Wu
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Stefan Winzeck
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Anne-Katrin Giese
    Department of Neurology, JP Kistler Stroke Research Center, MGH, Boston, MA (A.-K.G., M.R.E., K.D., M.D.S., N.S.R.)
  • Brandon L. Hancock
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Mark R. Etherton
    Department of Neurology, JP Kistler Stroke Research Center, MGH, Boston, MA (A.-K.G., M.R.E., K.D., M.D.S., N.S.R.)
  • Mark J.R.J. Bouts
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Kathleen Donahue
    Department of Neurology, JP Kistler Stroke Research Center, MGH, Boston, MA (A.-K.G., M.R.E., K.D., M.D.S., N.S.R.)
  • Markus D. Schirmer
    Department of Neurology, JP Kistler Stroke Research Center, MGH, Boston, MA (A.-K.G., M.R.E., K.D., M.D.S., N.S.R.)
  • Robert E. Irie
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Steven J.T. Mocking
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Elissa C. McIntosh
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Raquel Bezerra
    From Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown (O.W., S.W., B.L.H., M.J.R.J.B., R.E.I., S.J.T.M., E.C.M., R.B.)
  • Konstantinos Kamnitsas
    Department of Computing, Imperial College London, United Kingdom (K.K.)
  • Petrea Frid
    Department of Clinical Sciences Lund, Lund University, Sweden (P.F., J.W., A.G.L.)
  • Johan Wasselius
    Department of Clinical Sciences Lund, Lund University, Sweden (P.F., J.W., A.G.L.)
  • John W. Cole
    Department of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD (J.W.C., S.J.K.)
  • Huichun Xu
    Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (H.X., P.F.M., B.D.M.)
  • Lukas Holmegaard
    Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Sweden (L.H.)
  • Jordi Jiménez-Conde
    Department of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mèdiques), Universitat Autonoma de Barcelona, Spain (J.J.-C., J.R.)
  • Robin Lemmens
    Department of Neurosciences, Experimental Neurology, KU Leuven—University of Leuven (R.L.)
  • Eric Lorentzen
    Department of Laboratory Medicine, Institute of Biomedicine, the Sahlgrenska Academy at University of Gothenburg, Sweden (E.L., T.M.S., C.J.)
  • Patrick F. McArdle
    Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (H.X., P.F.M., B.D.M.)
  • James F. Meschia
    Department of Neurology, Mayo Clinic, Jacksonville, FL (J.F.M.)
  • Jaume Roquer
    Department of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mèdiques), Universitat Autonoma de Barcelona, Spain (J.J.-C., J.R.)
  • Tatjana Rundek
    Department of Neurology, Miller School of Medicine, University of Miami, The Evelyn F. McKnight Brain Institute, FL (T.R., R.L.S.)
  • Ralph L. Sacco
    Department of Neurology, Miller School of Medicine, University of Miami, The Evelyn F. McKnight Brain Institute, FL (T.R., R.L.S.)
  • Reinhold Schmidt
    Clinical Division of Neurogeriatrics, Department of Neurology, Medical University Graz, Austria (R.S.)
  • Pankaj Sharma
    Institute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), Egham, United Kingdom (P.S.)
  • Agnieszka Slowik
    Department of Neurology, Jagiellonian University Medical College, Krakow, Poland (A.S.)
  • Tara M. Stanne
    Department of Laboratory Medicine, Institute of Biomedicine, the Sahlgrenska Academy at University of Gothenburg, Sweden (E.L., T.M.S., C.J.)
  • Vincent Thijs
    Stroke Division, Florey Institute of Neuroscience and Mental Health, HDB, Australia (V.T.)
  • Achala Vagal
    Department of Radiology (A.V.), University of Cincinnati College of Medicine, OH
  • Daniel Woo
    Department of Neurology and Rehabilitation Medicine (D.W.), University of Cincinnati College of Medicine, OH
  • Stephen Bevan
    School of Life Science, University of Lincoln, United Kingdom (S.B.)
  • Steven J. Kittner
    Department of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD (J.W.C., S.J.K.)
  • Braxton D. Mitchell
    Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (H.X., P.F.M., B.D.M.)
  • Jonathan Rosand
    Henry and Allison McCance Center for Brain Health Massachusetts General Hospital, Boston (J.R.)
  • Bradford B. Worrall
    Departments of Neurology and Public Health Sciences, University of Virginia, Charlottesville (B.B.W.)
  • Christina Jern
    Department of Laboratory Medicine, Institute of Biomedicine, the Sahlgrenska Academy at University of Gothenburg, Sweden (E.L., T.M.S., C.J.)
  • Arne G. Lindgren
    Department of Clinical Sciences Lund, Lund University, Sweden (P.F., J.W., A.G.L.)
  • Jane Maguire
    University of Technology Sydney, Australia (J.M.).
  • Natalia S. Rost
    Department of Neurology, JP Kistler Stroke Research Center, MGH, Boston, MA (A.-K.G., M.R.E., K.D., M.D.S., N.S.R.)

抄録

<jats:sec> <jats:title>Background and Purpose—</jats:title> <jats:p>We evaluated deep learning algorithms’ segmentation of acute ischemic lesions on heterogeneous multi-center clinical diffusion-weighted magnetic resonance imaging (MRI) data sets and explored the potential role of this tool for phenotyping acute ischemic stroke.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods—</jats:title> <jats:p>Ischemic stroke data sets from the MRI-GENIE (MRI-Genetics Interface Exploration) repository consisting of 12 international genetic research centers were retrospectively analyzed using an automated deep learning segmentation algorithm consisting of an ensemble of 3-dimensional convolutional neural networks. Three ensembles were trained using data from the following: (1) 267 patients from an independent single-center cohort, (2) 267 patients from MRI-GENIE, and (3) mixture of (1) and (2). The algorithms’ performances were compared against manual outlines from a separate 383 patient subset from MRI-GENIE. Univariable and multivariable logistic regression with respect to demographics, stroke subtypes, and vascular risk factors were performed to identify phenotypes associated with large acute diffusion-weighted MRI volumes and greater stroke severity in 2770 MRI-GENIE patients. Stroke topography was investigated.</jats:p> </jats:sec> <jats:sec> <jats:title>Results—</jats:title> <jats:p> The ensemble consisting of a mixture of MRI-GENIE and single-center convolutional neural networks performed best. Subset analysis comparing automated and manual lesion volumes in 383 patients found excellent correlation (ρ=0.92; <jats:italic>P</jats:italic> <0.0001). Median (interquartile range) diffusion-weighted MRI lesion volumes from 2770 patients were 3.7 cm <jats:sup>3</jats:sup> (0.9–16.6 cm <jats:sup>3</jats:sup> ). Patients with small artery occlusion stroke subtype had smaller lesion volumes ( <jats:italic>P</jats:italic> <0.0001) and different topography compared with other stroke subtypes. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Automated accurate clinical diffusion-weighted MRI lesion segmentation using deep learning algorithms trained with multi-center and diverse data is feasible. Both lesion volume and topography can provide insight into stroke subtypes with sufficient sample size from big heterogeneous multi-center clinical imaging phenotype data sets.</jats:p> </jats:sec>

収録刊行物

  • Stroke

    Stroke 50 (7), 1734-1741, 2019-07

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ